Many factors are involved in inducing muscle wasting and derangements
of protein metabolism in chronic renal failure. Anorexia, low protein
intake, hormonal abnormalities (increased cortisol and parathyroid hor
mone secretion, and insulin resistance), acidosis, abnormalities of th
e cytokine system, and other unidentified uremic toxins create a negat
ive nitrogen balance and stimulate protein catabolism. The protein tur
nover rate (i.e., synthesis and degradation) is generally decreased in
non-acidotic uremic patients. However, in uncorrected acidosis, prote
in degradation is accelerated and a rapid loss of body proteins superv
enes. Nutrition can be improved in chronically uremic patients through
pharmacological therapy that can control protein catabolism. Administ
ration of growth hormone and insulin-like growth factor-1 has been sho
wn to be effective. These hormones influence both glucose and glutamin
e metabolism. Another approach is the administration of pentoxifylline
, which may have an anticatabolic effect by interfering with the tumor
necrosis factor-alpha system.